A Practical handbook on the pharmacovigilance of antimalarial medicines.

Contributor(s):

World Health Organization

Material type: Text

TextPublication details: Geneva, Switzerland : World Health Organization, c2008.Description: viii, 108 p. : ill. (some col.) ; 22 cmISBN:

9789241547499
9241547499

Subject(s):

DDC classification:

372.7/ WHO

LOC classification:

RM301.9 .P73 2008

Online resources:

Connect to online resource

Also available online.

Contents:

A. Introduction -- B. Passive or active pharmacovigilance? -- C. Spontaneous reporting -- D. Cohort event monitoring -- E. Data processing -- F. Special types of event -- G. Relationship/causality assessment -- H. Signal identification -- I. Strengthening the signal -- J. Identifying risk factors -- K. Analyses -- L. Differences between spontaneous reporting and cohort event monitoring -- M. Organization -- N. Communication -- Annex.

Summary: This publication is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antimalarials. It provides information on spontaneous reporting of adverse drug reactions as a complement to other WHO publications. In addition, it provides details on how to conduct cohort event monitoring, which is a method of active safety surveillance collecting information on all adverse events occurring after treatment. It also details how to perform causality assessment and signal identification, applicable to both methods of surveillance.--Publisher's description.

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Collection	Call number	Status	Date due	Barcode
Books	SUN - Main Library General Shelves	Text Books	372.7/ WHO (Browse shelf(Opens below))	Available		2018-4639

This publication is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antimalarials. It provides information on spontaneous reporting of adverse drug reactions as a complement to other WHO publications. In addition, it provides details on how to conduct cohort event monitoring, which is a method of active safety surveillance collecting information on all adverse events occurring after treatment. It also details how to perform causality assessment and signal identification, applicable to both methods of surveillance.--Publisher's description.

Also available online.

There are no comments on this title.

to post a comment.